Skip to main content
Premium Trial:

Request an Annual Quote

Stratos, nanoMR Co-developing Instrument for Pathogen Detection

NEW YORK (GenomeWeb News) – Stratos Product Development said today it is partnering with nanoMR to develop an instrument to rapidly isolate multiple cell types and more rapidly detect pathogens.

The instrument will be built on nanoMR's Pathogen Capture System, and will allow clinicians to begin appropriate antibiotic treatment sooner, leading to better patient outcomes, Seattle-based Stratos said.

"Stratos' development expertise, combined with nanoMR's chemistry and research, creates an ideal team to deliver an optimal solution for the market," Jim Macemon, vice president of product development for nanoMR, said in a statement.

Based in Albuquerque, NM, nanoMr develops diagnostic systems for isolating rare cell types, using an immunomagnetic capture process that can capture cells for phenotypic analysis or extracted DNA for molecular analysis.

Stratos will develop a cost-effective cassette and processing regimen with an input of up to a 10 milliliter blood sample and an output of 50 microliters containing purified DNA, Stratos said. In addition to developing the instrument, Stratos is performing hardware and software design with ISO 13485 design controls. It also is developing manufacturing strategies and performing verification activities with output to support CE certification for clinical trials in Europe.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.